Article: Exploring the new pharmaceuticals: an overview of behavioral drugs, near and future, with Angelo Sambunaris, MD, Atlanta Institute of Medicine and Research.

In all the clamor about the costs of prescription drugs and the need to limit pharmaceutical companies' patent protection (not to mention recent discussions about expanding prescribing privileges to psychologists), it' s easy to forget the improved quality of life that new and refined drugs could bring to sufferers of mental illness and substance abuse. For some foresight on what's up and coming in behavioral health pharmacy, Behavioral Health Management Managing Editor Douglas J. Edwards turned to Angelo Sambunaris, MD, the medical director of the Atlanta Institute of Medicine and Research in Marietta, Georgia, an outpatient CNS clinical trial facility focusing on ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!